Cytovance(R) Biologics Announces the Company is Providing Antibody cGMP Manufacturing for ImmunoGen, Inc.OKLAHOMA CITY Oklahoma City (1990 pop. 444,719), state capital, and seat of Oklahoma co., central Okla., on the North Canadian River; inc. 1890. The state's largest city, it is an important livestock market, a wholesale, distribution, industrial, and financial center, and a farm -- Cytovance([R]) Biologics LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian mammalian emanating from or pertaining to mammals. cell culture, today announced that ImmunoGen, Inc., a biotechnology company developing targeted anticancer therapeutics, has been added to its diverse and growing client portfolio. ImmunoGen chose Cytovance for process development, cell banking, and cGMP manufacturing of a proprietary ImmunoGen antibody. "We are very pleased to partner with ImmunoGen and provide manufacturing excellence to their products," said Darren Head President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Cytovance Biologics. "Our relationship with ImmunoGen is an excellent example of our business model, value, services and state-of-the-art facilities." ImmunoGen's project is executed out of Cytovance's multi-product cGMP production facility in Oklahoma City. The 44,000 sq. ft. facility meets the latest international regulatory standards and is custom-designed for efficient and cost-effective production. Cytovance specializes in the execution of clinical production of antibody and recombinant protein recombinant protein Molecular biology A protein encoded by recombinant DNA or generated from a recombinant gene. See Recombinant pharmacology. products derived from cell culture at scales up to 500L (w/v) from both fed-batch and perfusion perfusion /per·fu·sion/ (-zhun) 1. the act of pouring over or through, especially the passage of a fluid through the vessels of a specific organ. 2. a liquid poured over or through an organ or tissue. processes. "Our excellent working relationship with ImmunoGen's technical and Quality personnel has contributed directly to successful results from technology transfer through cell banking and cGMP manufacturing," said Steven Perry, Vice President of Manufacturing Operations Manufacturing operations concern the operation of a facility, as opposed to maintenance, supply and distribution, health, and safety, emergency response, human resources, security, information technology and other infrastructural support organizations. for Cytovance Biologics. "We look forward to continued collaboration with ImmunoGen." Cytovance was founded to help biopharmaceutical companies advance recombinant protein and antibody products rapidly and cost-effectively from the bench, through clinical development and into the international marketplace The company's approach couples considerable client-side experience with the necessary technical and operational expertise to deliver precision science, agile manufacture, and reasonable business that meet international regulatory standards and facilitate efficient completion of clinical development. About Cytovance Biologics Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. An experienced management team formed the company to address the biotechnology industry's increasing needs for full-service manufacturing capacity at the clinical and early commercial scale. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services from its Oklahoma City, Okla. facilities. For more information on Cytovance, visit www.cytovance.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion